Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taste receptor type 2 member 41 (TAS2R41) is a member of the bitter taste receptor family, which belongs to the G protein-coupled receptor (GPCR) superfamily[1]. This receptor is predominantly expressed in taste receptor cells of the tongue and palate epithelia and plays a key role in the perception of bitterness[1]. TAS2R41 has a seven-transmembrane domain structure characteristic of GPCRs and displays high selectivity for the antibiotic chloramphenicol as an agonist[1][2]. Upon ligand binding, TAS2R41 couples to the G protein α-gustducin, which activates phospholipase C-β2, leading to an increase in intracellular calcium and downstream signaling events that mediate the neuronal response to bitter compounds[3]. While primarily involved in taste sensation, some evidence suggests extraoral roles such as chemical sensing in the gastrointestinal tract[1][3]. TAS2R41 is not broadly tuned and is highly selective compared to other bitter taste receptors[2][3]. Mutations in this gene, or variants with impaired function, may affect an individual's sensitivity to specific bitter compounds[2]. TAS2R41 has been associated with submandibular gland conditions, although its disease relevance is still largely under investigation[1].
Agonist binding activates G protein α-gustducin, leading to PLC-β2 activation, increased intracellular calcium, and signal transduction in taste cells[1][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 2 member 41 (TAS2R41).